reperfusion therapy

reperfusion therapy

Cardiology Any therapy–eg, thrombolytic therapy-tPA, stenting, or immediate percutaneous transluminal coronary angioplasty-IPCTA–intended to ensure continued blood flow–and oxygenation through a vascular bed acutely compromised by vasospasm or thrombosis, especially post acute MI. See tPA, Trials.
Mentioned in ?
References in periodicals archive ?
In a multicenter, double-blind, randomized controlled trial, 116 patients with acute ST-elevation MI were randomly assigned to receive an intracoronary infusion of WJMSCs or placebo into the infarct artery at five to seven days after successful reperfusion therapy.
METHODS: In a multicenter trial, we randomly assigned 204 patients with acute myocardial infarction to receive an intracoronary infusion of progenitor cells derived from bone marrow (BMC) or placebo medium into the infarct artery 3 to 7 days after successful reperfusion therapy.
Patients receive one single injection of CicloMulsion (or placebo) prior to reperfusion therapy by stenting.
We found that a larger proportion of married and cohabiting men received reperfusion therapy at acute stage which may contribute to their better survival after hospitalisation.
Emergent angiogram and reperfusion therapy is suitable in those with STEMI and demonstrable coronary obstruction.
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
I recently travelled to Birmingham, Alabama, the United States, to complete the practical component of the online neurovascular education and training in stroke management and acute reperfusion therapy (NET SMART) course.
The AMI Virtual Learning Collaborative has been designed to address the timeliness of reperfusion therapy.
Revisiting reperfusion therapy in inferior myocardial infarction.
Roughly one-third of MI patients don't receive acute reperfusion therapy, most often because they present too late.
The widespread use of reperfusion therapy and cardiac medications with anti-inflammatory properties may have reduced the incidence of PCIS.
The study revealed women waited an average of 70 minutes for reperfusion therapy - which restores blood flow to the heart - compared with 52 minutes for men.

Full browser ?